Candriam SCA’s St Jude Medical STJ Stock Holding History

Candriam SCA’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-16,168	Closed	-$1.3M	–	721
2016 Q4	$1.3M	Sell	16,168 -8,847	-35%	-$702K	0.03%	465
2016 Q3	$2M	Buy	25,015 +2,643	+12%	+$213K	0.05%	354
2016 Q2	$1.75M	Sell	22,372 -50,068	-69%	-$3.57M	0.05%	335
2016 Q1	$3.96M	Sell	72,440 -228,951	-76%	-$12.5M	0.1%	225
2015 Q4	$18.6M	Buy	301,391 +99,154	+49%	+$6.25M	0.5%	47
2015 Q3	$12.8M	Buy	202,237 +41,310	+26%	+$2.95M	0.31%	92
2015 Q2	$11.8M	Sell	160,927 -72,055	-31%	-$5.21M	0.24%	112
2015 Q1	$15.2M	Buy	232,982 +106,712	+85%	+$7.1M	0.31%	81
2014 Q4	$8.21M	Buy	+126,270	New	+$8.13M	0.17%	172

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Candriam SCA's STJ Position: Q1 2017 in Review

Candriam SCA sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 16,168 shares — an estimated $1.3M sold.

Candriam SCA first reported a position in STJ in Q4 2014 and held it in 9 quarters. The position peaked at $18.6M in Q4 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Candriam SCA reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Candriam SCA sold 16,168 St Jude Medical shares in Q1 2017, an estimated $1.3M.
Candriam SCA first reported a position in St Jude Medical in Q4 2014 and held it in 9 quarters.
Candriam SCA's St Jude Medical position peaked at $18.6M in Q4 2015.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.